Kaplan-Meier analysis of 2898 breast cancer patients reveal that NURR1 is significantly associated with improved prognosis as determined by RFS, where HR = 0.7 (0.62-0.79, LogrankP = 2×10-8) (Figure 3A). Here, NR4A2 is linked to breast carcinoma.